Register

I agree with the Privacy Policy

Los Angeles Times

Medical giant Medtronic to buy rival Covidien for $42.9 billion

June 15, 2014

Because both companies already are giants in the medical-devices market, the merger should allow for more robust research and development and more comprehensive health-monitoring capabilities, said Harry Wang, a health industry analyst at product research firm Parks Associates.

The medical devices industry has been plagued by slow innovation, but the merger should advance the market, Wang said.

“By buying up this company and consolidating R&D spending, they have a better chance of getting their products to market,” he said. “Over the long term, if R&D is spent wisely and effectively, you will see more cost-effective products for consumers.”

From the article, "Medical giant Medtronic to buy rival Covidien for $42.9 billion" by Javier Panzar.

Previously In The News

Why not pull the plug on cable

Not subscribing to a cable, satellite or telco provider does have some downsides. It means saying goodbye to ESPN and other popular networks that air things as they happen, although some news servi...

Now showing in rich people's homes: first-run movies

"There are thousands of people out there, if not tens of thousands of people, that could buy this product," Pang said. "We found the secret sauce to make billionaires act like little giddy schoolch...

Hard-core gamers turning to social networks

It's not just time. "Camelot" players also spend more money. The average social game on Facebook succeeds in getting between 2 percent and 5 percent of players to spend money on the game, according...

Former Apple exec markets a thermostat for the iPhone generation

Getting the average homeowner to take an interest — and make an investment — in managing energy is a chronic problem for the industry. But it's the wave of the future, and utilities, service provid...

‹
1
2
3
4
5
6
7
8
9
10
›